| 摘要 |
Described is the use of a non-absorbable, non-digestible lipid, for the manufacture of a pharmaceutical or dietary composition for the treatment of hyperbilirubinemia, specifically unconjugated hyperbilirubinemia such as neonatal jaundice, Crigler-Najjar syndrom and Gilbert syndrom. |
